22 Oct 2019 --- Microalgae-based natural solutions company Microphyt has received New Dietary Ingredient (NDI) status from the US Food and Drug Administration (FDA) for its patented PhaeoSOL dietary ingredient. Proprietary preclinical data on PhaeoSOL have demonstrated significant nutritional benefits in the prevention of age-related cognitive decline. Microphyt is the first European microalgae company to receive NDI Status from the FDA.
